Anebulo Pharmaceuticals Inc

NASDAQ:ANEB  
3.20
+0.34 (+11.89%)
Earnings Announcements

Anebulo Pharmaceuticals reports Q4 results

Published: 09/09/2022 12:07 GMT
Anebulo Pharmaceuticals Inc (ANEB) - Anebulo Pharmaceuticals Reports Fourth Quarter and Fiscal Year 2022 Financial Results and Highlights Recent Business Progress.
Anebulo Pharmaceuticals Inc - Cash Balance Was $14.5 Million As of June 30, 2022.
Anebulo Pharmaceuticals Inc - Net Loss in Q4 of Fiscal 2022 Was $2.3 Million, Or $0.10 per Share.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.11

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.11

More details on our Analysts Page.